Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 7
2005 3
2006 3
2007 2
2008 2
2009 4
2010 8
2011 11
2012 7
2013 11
2014 4
2015 15
2016 5
2017 3
2018 4
2019 3
2020 4
2021 6
2022 3
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Effects of switching from agalsidase-α to agalsidase-β on biomarkers, renal and cardiac parameters, and disease severity in fabry disease forming neutralizing antidrug antibodies: a case report.
Shima H, Tsukimura T, Shiga T, Togawa T, Sakuraba H, Doi T, Ikeda Y, Okamoto T, Yoshikawa Y, Kimura T, Iwase T, Inoue T, Tashiro M, Okada K, Minakuchi J. Shima H, et al. Among authors: okada k. CEN Case Rep. 2023 Dec 22. doi: 10.1007/s13730-023-00843-1. Online ahead of print. CEN Case Rep. 2023. PMID: 38135868 Free article.
X-linked Alport Syndrome with Type IV Collagen α5 Chain Staining Revealing Normal Expression in the Glomerular Basement Membrane and Negative on Bowman's Capsule and Distal Tubular Basement Membrane: A Case Report.
Okamoto T, Shima H, Doi T, Nozu K, Inoue T, Tashiro M, Wariishi S, Bando H, Azuma H, Iwasaka N, Ohara T, Okada K, Minakuchi J. Okamoto T, et al. Among authors: okada k. Tohoku J Exp Med. 2023 Sep 20;261(1):69-73. doi: 10.1620/tjem.2023.J060. Epub 2023 Jul 27. Tohoku J Exp Med. 2023. PMID: 37495524 Free article.
Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.
Maruyama S, Kurasawa S, Hayashi T, Nangaku M, Narita I, Hirakata H, Tanabe K, Morita S, Tsubakihara Y, Imai E, Akizawa T; PREDICT Investigators. Maruyama S, et al. Clin Exp Nephrol. 2023 Sep;27(9):757-766. doi: 10.1007/s10157-023-02362-w. Epub 2023 Jun 8. Clin Exp Nephrol. 2023. PMID: 37289335 Free PMC article. Clinical Trial.
Low-density Lipoprotein Receptor Activities, Lipids, Apolipoprotein, and Clinical Course of Patients with Steroid-resistant Nephrotic Syndrome Treated with Low-density Lipoprotein Apheresis: A Case Series.
Shima H, Higashiguchi Y, Doi T, Harada M, Okamoto T, Inoue T, Tashiro M, Okada K, Minakuchi J. Shima H, et al. Among authors: okada k. Intern Med. 2024 Feb 1;63(3):433-438. doi: 10.2169/internalmedicine.1922-23. Epub 2023 May 31. Intern Med. 2024. PMID: 37258157 Free PMC article.
Successful Treatment of Nephrotic Syndrome Due to Collapsing Focal Segmental Glomerulosclerosis Accompanied by Acute Interstitial Nephritis.
Shima H, Doi T, Okamoto T, Higashiguchi Y, Harada M, Inoue T, Tashiro M, Wariishi S, Takamatsu N, Kawahara K, Okada K, Minakuchi J. Shima H, et al. Among authors: okada k. Intern Med. 2022 Jun 15;61(12):1863-1867. doi: 10.2169/internalmedicine.8258-21. Epub 2021 Nov 20. Intern Med. 2022. PMID: 34803098 Free PMC article.
100 results